CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 clinical trial of inhaled insulin powder for type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED